GLMD · Galmed Pharmaceuticals Ltd.
$0.51
-0.01 (-1.84%)
At close · Aug 17
Market Cap
$4.24M
Shares
8.26M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-08-17 | — | |
| 6-K | 2026-08-14 | — | |
| 6-K | 2026-07-31 | — | |
| 6-K | 2026-07-29 | — | |
| 6-K | 2026-07-28 | — | |
| 6-K | 2026-07-22 | — | |
| 6-K | 2026-07-16 | — | |
| 6-K | 2026-07-08 | — | |
| 6-K | 2026-06-22 | — | |
| 6-K | 2026-06-08 | — | |
| 6-K | 2026-06-02 | — | |
| 6-K | 2026-05-14 | — | |
| 6-K | 2026-05-06 | — | |
| 6-K | 2026-04-14 | — | |
| 6-K | 2026-04-09 | — | |
| 20-F | 2026-03-31 | 2025-12-31 | |
| 6-K | 2026-03-05 | — | |
| 6-K | 2026-03-04 | — | |
| 6-K | 2026-02-09 | — | |
| 6-K | 2026-01-30 | — | |
| 6-K | 2025-12-08 | — | |
| 6-K | 2025-12-04 | — | |
| 6-K | 2025-12-01 | — | |
| 6-K | 2025-11-26 | 2025-09-30 | |
| 6-K | 2025-11-18 | — | |
| 6-K | 2025-11-17 | — | |
| 6-K | 2025-10-29 | — | |
| 6-K | 2025-10-28 | — | |
| 6-K | 2025-09-19 | — | |
| 6-K | 2025-08-28 | 2025-06-30 | |
| 6-K | 2025-08-25 | — | |
| 6-K | 2025-08-15 | — | |
| 6-K | 2025-08-14 | — | |
| 6-K | 2025-07-24 | — | |
| 6-K | 2025-05-27 | — | |
| 6-K | 2025-05-22 | — | |
| 6-K | 2025-05-13 | — | |
| 6-K | 2025-05-06 | — | |
| 6-K | 2025-04-28 | — | |
| 6-K | 2025-04-17 | — | |
| 6-K | 2025-04-15 | — | |
| 6-K | 2025-04-10 | — | |
| 20-F | 2025-04-02 | 2024-12-31 | |
| 6-K | 2025-03-20 | — | |
| 6-K | 2024-11-14 | — | |
| 6-K | 2024-11-14 | — | |
| 6-K | 2024-10-21 | — | |
| 6-K | 2024-10-15 | — | |
| 6-K | 2024-09-25 | — | |
| 6-K | 2024-09-20 | — |
Showing 1–50 of 135 filings
Key facts
CIK
1595353
CUSIP
M47238148
13F (30d)
13 filings
13 filers
Visit website
Investor relations